Navigation Links
LamdaGen Corporation Issued United States Patent for Diagnostics on Plasmonic-Based Nanosensors
Date:4/24/2013

MENLO PARK, Calif., April 24, 2013 /PRNewswire/ -- LamdaGen Corporation, a nano-technology platform company that provides plasmonic sensors and systems for diagnostics and life sciences, announced the United State Patent and Trademark Office (USTPO) issuance of patent "Enzymatic Assays for LSPR" for performing quantitative diagnostics via Localized Surface Plasmon Resonance (LSPR). 

The patent claims broadly cover plasmonic surfaces and nano-particles used for LSPR-oriented ELISA. The Company's proprietary LSPR metallic thin-films are easily grown onto practically any solid support, thereby allowing compatibility with a wide range of current IVD systems — including plate-based throughput platforms and rapid diagnostic systems for Point-of-Care.

"Our plasmonic ELISA provides for rapid quantitative detection with excellent reproducibility at sensitivity levels exceeding conventional ELISAs by as much as four orders of magnitude," commented Randy Storer , CEO and Co-Founder of LamdaGen Corporation. "The issuance of this patent illustrates LamdaGen's unique ability to harness modern plasmonics for advancing In-Vitro Diagnostics (IVD)."

This patent is the latest addition to LamdaGen's growing global IP portfolio for plasmonic-based nano-applications in diagnostics, contaminant-monitoring and life science research.

About LamdaGen Corporation
LamdaGen is a nano-technology platform company providing plasmonic sensors and analytical systems for diagnostic and life science markets. The company's Localized Surface Plasmon Resonance (LSPR) sensors and systems enable real-time detection of biomolecular interactions, as well as enzymatic and chemical reactions. LamdaGen is a privately held company headquartered in Menlo Park, California and is the first to offer commercial LSPR products. For more information, visit www.lamdagen.com or email info@lamdagen.com

Media Contact:
Alice F. Huang
650-571-5816
ahuang@lamdagen.com


'/>"/>
SOURCE LamdaGen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
3. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
4. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
5. Luminex Corporation Reports First Quarter 2012 Results
6. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
7. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
8. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
11. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... and technology platform for value-based precision medicine, ... multi-year collaboration with Novartis Pharmaceuticals Corporation to ... breast cancer patients. As part ... the previous announced collaboration entered into January ...
(Date:3/27/2017)... 2017 Arena Pharmaceuticals, Inc. (NASDAQ: ... small molecule drugs across multiple therapeutic areas, today announced that ... will present a corporate update at the 16th Annual Needham ... conference will take place April 4-5, 2017 at the Westin ... , NY.  A live audio webcast of ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a ... year in a row; they are the recipient of the prestigious “Best Overall ... on the award at Design Connections 2017. Top A&D professionals from leading firms, ...
(Date:3/27/2017)... Switzerland (PRWEB) , ... March 27, 2017 , ... ... food industry. Conventional sodium testing methods are complicated and require expert user knowledge. ... a new analytical method dedicated to the simplified, yet highly accurate, determination of ...
(Date:3/27/2017)... Clearwater, Fla. (PRWEB) , ... March 27, 2017 , ... ... (1) and the number of homeowners utilizing DIY and unlicensed contractors for renovations is ... bathroom remodel or replacement project in 2015, and of those, 42% failed to use ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... contaminated soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition ... This acquisition will add four additional processing facilities and a vast array ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management ... . The annual awards, now in their 12th year, are among the most prestigious ... , In 2016, the awards were retooled to recognize achievements in both large budget ...
Breaking Medicine News(10 mins):